Incorporating radiation with anti-CD19 chimeric antigen receptor T-cell therapy for relapsed/refractory non-Hodgkin lymphoma: A multicenter consensus approach.
Am J Hematol
; 99(1): 124-134, 2024 Jan.
Article
in En
| MEDLINE
| ID: mdl-37950857
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lymphoma, Non-Hodgkin
/
Receptors, Chimeric Antigen
Limits:
Humans
Language:
En
Journal:
Am J Hematol
Year:
2024
Document type:
Article